Temozolomide use in adult patients with gliosarcoma: An evolving clinical practice

Journal of Neuro-Oncology

Volumn 112, Issue 1, 2013, Pages 83-89

  Walker, Gary V ^a   Gilbert, Mark R ^a   Prabhu, Sujit S ^a   Brown, Paul D ^a,b   McAleer, Mary Frances ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Gliosarcoma; Radiation therapy; SEER; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; EARLY MODERN PERIOD; EVOLUTION; FEMALE; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OVERALL SURVIVAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEX DIFFERENCE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; FEMALE; GLIOSARCOMA; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874657703     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-1029-7     Document Type: Article

References (26)

1. Miller CR, Perry A (2007) Glioblastoma. Arch Pathol Lab Med 131(3):397-406
2. Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH et al (1998) Clinical outcome of gliosarcoma compared with glioblastoma multiforme: north central cancer treatment group results. J Neurosurg 89(3):425-430 (Pubitemid 28405257)
3. Kozak KR, Mahadevan A, Moody JS (2009) Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol 11(2):183-191
4. Lutterbach J, Guttenberger R, Pagenstecher A (2001) Gliosarcoma: a clinical study. Radiother Oncol 61(1):57-64 (Pubitemid 32913462)
5. Walker GV, Li J, Mahajan A, McAleer MF, de Groot JF, Azeem SS, Brown PD (2012) Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme: a population-based analysis. Cancer 118(18):4538-4544
6. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527-1535 (Pubitemid 46588417)
7. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49(3):333-343 (Pubitemid 9013313)
8. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R et al (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the scandinavian glioblastoma study group. Cancer 47(4):649-652 (Pubitemid 11135858)
9. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996 (Pubitemid 40349501)
10. National comprehensive cancer network clinical practice guidelines in oncology, central nervous system cancers v.2.2011 [Internet].; cited 2/17/2012]. Available from: http://www.nccn.org/professionals/physician-gls/pdf/cns.pdf
11. Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER program of the national cancer institute. Cancer 76(11):2343-2350
12. Surveillance, epidemiology and end results (SEER) program [Internet]. Available from: http://seer.cancer.gov/
13. Surveillance, epidemiology, and end results (SEER) program SEER*Stat database: Incidence - SEER 17 regs limited-use + hurricane katrina impacted louisiana cases, nov 2008 sub (1973-2006 varying) - linked to county attributes - total U.S., 1969-2006 counties, national cancer institute, DCCPS, surveillance research program, cancer statistics branch, released April 2009, based on the November 2008 submission
14. Housman DM, Decker RH, Wilson LD (2007) Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival. J Clin Oncol 25(28):4503-4504 author reply 4504-4505 (Pubitemid 350013863)
15. Zhang BY, Chen H, Geng DY, Yin B, Li YX, Zhong P et al (2011) Computed tomography and magnetic resonance features of gliosarcoma: a study of 54 cases. J Comput Assist Tomogr 35(6):667-673
16. Lee D, Kang SY, Suh YL, Jeong JY, Lee JI, Nam DH (2012) Clinicopathologic and genomic features of gliosarcomas. J Neurooncol 107(3):643-650
17. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5 year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459-466
18. Han SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW et al (2010) Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 116(5):1358-1366
19. Han SJ, Yang I, Tihan T, Chang SM, Parsa AT (2010) Secondary gliosarcoma: a review of clinical features and pathological diagnosis. J Neurosurg 112(1):26-32
20. Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan T, McDermott MW et al (2010) Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 112(5):990-996
21. Mason WP, Cairncross JG (2005) Drug insight: temozolomide as a treatment for malignant glioma - impact of a recent trial. Nat Clin Pract Neurol 1(2):88-95
22. Cohen MH, Johnson JR, Pazdur R (2005) Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 11(19 Pt 1):6767-6771 (Pubitemid 41428729)
23. Darefsky AS, King JT Jr, Dubrow R (2011) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer 118(8):2163-2172
24. Johnson DR, O'Neill BP (2011) Glioblastoma survival in the united states before and during the temozolomide era. J Neurooncol 107(2):359-364
25. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392-401
26. Salvati M, Caroli E, Raco A, Giangaspero F, Delfini R, Ferrante L (2005) Gliosarcomas: analysis of 11 cases do two subtypes exist? J Neurooncol 74(1):59-63 (Pubitemid 41194532)